Nombre del producto:1,2,3,5,6,7-Hexahydro-s-indacen-4-amine

IUPAC Name:1,2,3,5,6,7-hexahydro-s-indacen-4-amine

CAS:63089-56-5
Fórmula molecular:C12H15N
Pureza:95%
Número de catálogo:CM219878
Peso molecular:173.26

Unidad de embalaje Stock disponible Precio($) Cantidad
CM219878-25g in stock ǧǧɅ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :63089-56-5
Fórmula molecular:C12H15N
Punto de fusión:-
Código de sonrisas:NC1=C2CCCC2=CC3=C1CCC3
Densidad:
Número de catálogo:CM219878
Peso molecular:173.26
Punto de ebullición:
Nº Mdl:
Almacenamiento:Keep in dark place, inert atmosphere, store at room temperature.

Category Infos

Indenes
Indenes are useful building blocks found in a variety of biologically relevant products.

Column Infos

Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.
NT-0796
NodThera’s NLRP3 inhibitor NT-0796 reverses neuroinflammation in Parkinson’s Disease phase Ib/IIa trial. The positive data from its Phase Ib/IIa study indicates that NT-0796 reduces key neuroinflammatory and inflammatory biomarkers in Parkinson’s disease patients to the levels found in healthy elderly controls over 28 days.
The NLRP3 inflammasome is a main mediator of inflammation in many pathologies. NT-0796 selectively inhibits NLRP3, lowering levels of both pro-inflammatory cytokines IL-1β and IL-18. This action delivers therapeutic effects directly to immune cell types responsible for inflammatory diseases, including peripheral and neuroinflammatory diseases.